Published in AIDS Weekly, December 4th, 1995
Researcher Nadim Salomon and colleagues also found that improved outcomes can be achieved in HIV infected multidrug resistant tuberculosis (MDR-TB) patients when they are prospectively identified and treated with agents that are active in vitro ("Predictors and Outcome of MDR-TB," Clinical Infectious Diseases, November 1995;21:1245-1252).
"Outbreaks of MDR-TB that are associated with nearly 100 percent bacteriologic failure and high early mortality have recently...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.